Integra LifeSciences Holdings Corporation Company Profile (NASDAQ:IART)

About Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Integra LifeSciences Holdings Corporation logoIntegra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:IART
  • CUSIP: 45798520
  • Web: www.integralife.com
Capitalization:
  • Market Cap: $4.16 billion
  • Outstanding Shares: 75,620,000
Average Prices:
  • 50 Day Moving Avg: $53.45
  • 200 Day Moving Avg: $46.43
  • 52 Week Range: $37.71 - $56.42
P/E:
  • Trailing P/E Ratio: 65.52
  • Foreward P/E Ratio: 24.79
  • P/E Growth: 2.49
Sales & Book Value:
  • Annual Revenue: $1.01 billion
  • Price / Sales: 4.12
  • Book Value: $11.33 per share
  • Price / Book: 4.86
Profitability:
  • EBIDTA: $235.27 million
  • Net Margins: 6.66%
  • Return on Equity: 16.67%
  • Return on Assets: 7.36%
Debt:
  • Debt-to-Equity Ratio: 1.00%
  • Current Ratio: 3.02%
  • Quick Ratio: 1.75%
Misc:
  • Average Volume: 528,567 shs.
  • Beta: 0.75
  • Short Ratio: 10.23
 
Frequently Asked Questions for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

What is Integra LifeSciences Holdings Corporation's stock symbol?

Integra LifeSciences Holdings Corporation trades on the NASDAQ under the ticker symbol "IART."

When did Integra LifeSciences Holdings Corporation's stock split? How did Integra LifeSciences Holdings Corporation's stock split work?

Integra LifeSciences Holdings Corporation's stock split before market open on Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly created shares were issued to shareholders after the market closes on Wednesday, December 21st 2016. An investor that had 100 shares of Integra LifeSciences Holdings Corporation stock prior to the split would have 200 shares after the split.

How were Integra LifeSciences Holdings Corporation's earnings last quarter?

Integra LifeSciences Holdings Corporation (NASDAQ:IART) posted its quarterly earnings data on Wednesday, April, 26th. The company reported $0.39 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.40 by $0.01. The business earned $258.60 million during the quarter, compared to analysts' expectations of $254.19 million. Integra LifeSciences Holdings Corporation had a return on equity of 16.67% and a net margin of 6.66%. The business's quarterly revenue was up 9.2% compared to the same quarter last year. During the same period last year, the business posted $0.38 EPS. View Integra LifeSciences Holdings Corporation's Earnings History.

What guidance has Integra LifeSciences Holdings Corporation issued on next quarter's earnings?

Integra LifeSciences Holdings Corporation issued an update on its FY17 earnings guidance on Wednesday, April, 26th. The company provided EPS guidance of $1.88-1.94 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.91. The company issued revenue guidance of $1.12-1.14 billion, compared to the consensus revenue estimate of $1.13 billion.

Where is Integra LifeSciences Holdings Corporation's stock going? Where will Integra LifeSciences Holdings Corporation's stock price be in 2017?

9 brokerages have issued 1 year price targets for Integra LifeSciences Holdings Corporation's shares. Their forecasts range from $42.00 to $65.00. On average, they expect Integra LifeSciences Holdings Corporation's stock price to reach $52.06 in the next twelve months. View Analyst Ratings for Integra LifeSciences Holdings Corporation.

Who are some of Integra LifeSciences Holdings Corporation's key competitors?

Who are Integra LifeSciences Holdings Corporation's key executives?

Integra LifeSciences Holdings Corporation's management team includes the folowing people:

  • Stuart M. Essig Ph.D., Independent Chairman of the Board
  • Peter J. Arduini, President, Chief Executive Officer, Director
  • Glenn G. Coleman, Chief Financial Officer, Principal Accounting Officer, Corporate Vice President
  • Lisa Evoli, Corporate Vice President, Chief Human Resources Officer
  • Kenneth Burhop Ph.D., Chief Scientific Officer, Corporate Vice President
  • John Mooradian, Corporate Vice President - Global Operations and Supply Chain
  • Richard D. Gorelick, Corporate Vice President, General Counsel, Administration, Secretary
  • Robert T. Davis Jr., Corporate Vice President, President — Specialty Surgical Solutions
  • Judith E. O'Grady R.N., Corporate Vice President - Global Regulatory Affairs
  • Daniel L. Reuvers, Corporate Vice President, President - Specialty Surgical Solutions

Who owns Integra LifeSciences Holdings Corporation stock?

Integra LifeSciences Holdings Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Fisher Asset Management LLC (1.34%), Vaughan Nelson Investment Management L.P. (1.19%), First National Bank of Omaha (0.04%), Nisa Investment Advisors LLC (0.03%), Louisiana State Employees Retirement System (0.03%) and US Bancorp DE (0.03%). Company insiders that own Integra LifeSciences Holdings Corporation stock include Christian S Schade, Daniel L Reuvers, Glenn Coleman, James M Sullivan, Joseph Vinhais, Peter J Arduini, Raymond G Murphy, Richard D Gorelick and Stuart Essig. View Institutional Ownership Trends for Integra LifeSciences Holdings Corporation.

Who sold Integra LifeSciences Holdings Corporation stock? Who is selling Integra LifeSciences Holdings Corporation stock?

Integra LifeSciences Holdings Corporation's stock was sold by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C., Fisher Asset Management LLC, Independent Portfolio Consultants Inc., First National Bank of Omaha, Capstone Asset Management Co., Dubuque Bank & Trust Co. and Diversified Trust Co. Company insiders that have sold Integra LifeSciences Holdings Corporation stock in the last year include Glenn Coleman, James M Sullivan, Peter J Arduini, Raymond G Murphy, Richard D Gorelick and Stuart Essig. View Insider Buying and Selling for Integra LifeSciences Holdings Corporation.

Who bought Integra LifeSciences Holdings Corporation stock? Who is buying Integra LifeSciences Holdings Corporation stock?

Integra LifeSciences Holdings Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Vaughan Nelson Investment Management L.P., Mitsubishi UFJ Asset Management UK Ltd., V Wealth Management LLC, State of Alaska Department of Revenue, Cutler Group LP, Aperio Group LLC, Nisa Investment Advisors LLC and US Bancorp DE. View Insider Buying and Selling for Integra LifeSciences Holdings Corporation.

How do I buy Integra LifeSciences Holdings Corporation stock?

Shares of Integra LifeSciences Holdings Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Integra LifeSciences Holdings Corporation's stock price today?

One share of Integra LifeSciences Holdings Corporation stock can currently be purchased for approximately $55.04.


MarketBeat Community Rating for Integra LifeSciences Holdings Corporation (NASDAQ IART)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  225 (Vote Outperform)
Underperform Votes:  228 (Vote Underperform)
Total Votes:  453
MarketBeat's community ratings are surveys of what our community members think about Integra LifeSciences Holdings Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Integra LifeSciences Holdings Corporation (NASDAQ:IART) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 7 Buy Ratings
Consensus Rating:Buy (Score: 2.78)
Consensus Price Target: $52.06 (5.42% downside)

Analysts' Ratings History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/10/2017Cantor FitzgeraldReiterated RatingOverweight$65.00LowView Rating Details
6/24/2017Oppenheimer Holdings, Inc.Set Price TargetBuy$60.00LowView Rating Details
5/31/2017Jefferies Group LLCBoost Price TargetBuy$52.00 -> $58.00LowView Rating Details
5/2/2017Royal Bank Of CanadaReiterated RatingSector Perform -> Sector Perform$46.00 -> $48.00LowView Rating Details
3/22/2017Piper Jaffray CompaniesReiterated RatingOverweight$47.00LowView Rating Details
1/13/2017Barclays PLCReiterated RatingEqual Weight$84.00 -> $42.00N/AView Rating Details
1/6/2017JMP SecuritiesUpgradeMarket Perform -> Outperform$50.00N/AView Rating Details
10/28/2016Lake Street CapitalUpgradeHold -> Buy$46.00N/AView Rating Details
9/23/2016ArgusBoost Price TargetBuy$45.00 -> $52.50N/AView Rating Details
7/13/2016J P Morgan Chase & CoInitiated CoverageOverweightN/AView Rating Details
11/12/2015Citigroup Inc.Initiated CoverageBuy$37.50N/AView Rating Details
9/21/2015Bank of America CorporationUpgradeNeutral -> Buy$36.00 -> $39.50N/AView Rating Details
7/29/2015Raymond James Financial, Inc.UpgradeMarket Perform -> OutperformN/AView Rating Details
(Data available from 7/23/2015 forward)

Earnings

Earnings History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Earnings by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Earnings History by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ IART)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2017Q1 17$0.40$0.39$254.19 million$258.60 millionViewN/AView Earnings Details
2/23/2017Q4 2016$0.52$0.52$257.27 million$255.70 millionViewN/AView Earnings Details
10/27/2016Q3$0.89$0.93$249.30 million$250.30 millionViewListenView Earnings Details
7/28/2016Q216$0.76$0.79$243.17 million$249.30 millionViewListenView Earnings Details
4/27/2016Q116$0.73$0.74$230.66 million$236.80 millionViewListenView Earnings Details
2/25/2016Q4$0.86$0.87$241.11 million$241.20 millionViewListenView Earnings Details
11/3/2015Q315$0.74$0.75$224.08 million$226.40 millionViewListenView Earnings Details
7/30/2015Q215$0.73$0.79$239.91 million$244.10 millionViewListenView Earnings Details
4/30/2015Q115$0.63$0.76$229.69 million$233.70 millionViewN/AView Earnings Details
2/24/2015Q414$0.89$0.94$244.39 million$252.20 millionViewListenView Earnings Details
11/3/2014Q314$0.74$0.76$233.50 million$229.70 millionViewListenView Earnings Details
8/5/2014Q214$0.63$0.68$229.32 million$231.40 millionViewN/AView Earnings Details
5/1/2014Q114$0.58$0.57$213.30 million$215.00 millionViewN/AView Earnings Details
2/25/2014Q413$0.81$0.78$223.37 million$220.80 millionViewN/AView Earnings Details
10/28/2013Q313$0.70$0.72$214.05 million$213.20 millionViewN/AView Earnings Details
8/1/2013Q2 2013$0.55$0.60$207.30 million$205.50 millionViewN/AView Earnings Details
5/2/2013Q1 2013$0.37$0.39$195.20 million$196.70 millionViewN/AView Earnings Details
2/21/2013Q4 2012$0.76$0.78$215.90 million$214.40 millionViewN/AView Earnings Details
10/24/2012$0.77$0.85ViewN/AView Earnings Details
7/26/2012$0.69$0.74ViewN/AView Earnings Details
4/25/2012$0.60$0.71ViewN/AView Earnings Details
2/23/2012$0.55$0.72ViewN/AView Earnings Details
10/31/2011$0.77$0.77ViewN/AView Earnings Details
7/28/2011$0.61$0.70ViewN/AView Earnings Details
4/28/2011$0.66$0.66ViewN/AView Earnings Details
2/24/2011$0.73$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
2017 EPS Consensus Estimate: $1.92
2018 EPS Consensus Estimate: $2.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.38$0.48$0.42
Q2 20174$0.43$0.47$0.45
Q3 20174$0.42$0.52$0.49
Q4 20174$0.54$0.60$0.57
Q1 20182$0.46$0.51$0.49
Q2 20182$0.51$0.55$0.53
Q3 20182$0.57$0.57$0.57
Q4 20182$0.65$0.70$0.68
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Insider Ownership Percentage: 21.40%
Institutional Ownership Percentage: 89.70%
Insider Trades by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Institutional Ownership by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Insider Trades by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/25/2017Stuart EssigDirectorSell135,000$49.90$6,736,500.00View SEC Filing  
5/23/2017Stuart EssigDirectorSell140,000$48.01$6,721,400.00View SEC Filing  
5/4/2017Glenn ColemanVPSell13,865$45.91$636,542.15View SEC Filing  
5/4/2017James M SullivanDirectorSell15,658$45.89$718,545.62View SEC Filing  
11/8/2016Peter J ArduiniCEOSell24,009$79.51$1,908,955.59View SEC Filing  
8/23/2016Raymond G MurphyDirectorSell2,600$86.64$225,264.00View SEC Filing  
8/9/2016Peter J ArduiniCEOSell24,009$84.52$2,029,240.68View SEC Filing  
8/4/2016Raymond G MurphyDirectorSell2,610$84.83$221,406.30View SEC Filing  
8/1/2016Richard D GorelickVPSell4,000$84.60$338,400.00View SEC Filing  
5/9/2016Joseph VinhaisVPSell972$73.36$71,305.92View SEC Filing  
5/4/2016Glenn ColemanCFOSell3,563$70.62$251,619.06View SEC Filing  
5/3/2016Christian S SchadeDirectorSell7,829$70.42$551,318.18View SEC Filing  
5/2/2016Daniel L ReuversVPSell1,000$71.43$71,430.00View SEC Filing  
4/29/2016Richard D GorelickVPSell4,000$70.72$282,880.00View SEC Filing  
4/27/2016Stuart EssigDirectorSell104,390$70.15$7,322,958.50View SEC Filing  
4/6/2016Stuart EssigDirectorSell21,100$66.19$1,396,609.00View SEC Filing  
4/5/2016Stuart EssigDirectorSell83,290$66.68$5,553,777.20View SEC Filing  
4/4/2016Stuart EssigDirectorSell42,150$67.26$2,835,009.00View SEC Filing  
5/7/2015Stuart EssigDirectorSell75,000$64.32$4,824,000.00View SEC Filing  
5/6/2015Stuart EssigDirectorSell125,000$64.83$8,103,750.00View SEC Filing  
1/2/2015Judith OgradyVPSell3,500$53.33$186,655.00View SEC Filing  
10/28/2014Stuart EssigDirectorSell147,098$49.58$7,293,118.84View SEC Filing  
10/27/2014Stuart EssigDirectorSell41,268$49.56$2,045,242.08View SEC Filing  
9/2/2014Judith OgradyVPSell2,500$49.82$124,550.00View SEC Filing  
8/27/2014Richard D GorelickVPSell7,000$50.03$350,210.00View SEC Filing  
8/25/2014John B Henneman IIICAOSell20,000$50.12$1,002,400.00View SEC Filing  
8/22/2014Deborah A LeonettiVPSell1,000$50.96$50,960.00View SEC Filing  
8/8/2014Brian LarkinVPSell1,947$48.28$94,001.16View SEC Filing  
7/30/2014Stuart EssigDirectorSell50,800$47.76$2,426,208.00View SEC Filing  
7/23/2014Stuart EssigDirectorSell27,819$47.80$1,329,748.20View SEC Filing  
7/1/2014Judith OgradyVPSell2,500$47.54$118,850.00View SEC Filing  
6/23/2014Stuart EssigDirectorSell21,381$47.76$1,021,156.56View SEC Filing  
4/3/2014Stuart EssigDirectorSell6,344$46.01$291,887.44View SEC Filing  
4/2/2014Stuart EssigDirectorSell76,177$46.05$3,507,950.85View SEC Filing  
3/31/2014Stuart EssigDirectorSell17,479$46.05$804,907.95View SEC Filing  
3/10/2014Deborah LeonettiVPSell7,563$49.22$372,250.86View SEC Filing  
3/4/2014Richard GorelickVPSell2,000$47.98$95,960.00View SEC Filing  
2/28/2014Christian SchadeDirectorSell7,500$47.06$352,950.00View SEC Filing  
2/27/2014Brian LarkinVPSell3,265$46.15$150,679.75View SEC Filing  
2/27/2014John Henneman IIICFOSell5,000$46.07$230,350.00View SEC Filing  
1/16/2014Stuart EssigDirectorSell8,037$49.59$398,554.83View SEC Filing  
1/14/2014Stuart EssigDirectorSell10,600$49.50$524,700.00View SEC Filing  
1/13/2014Stuart EssigDirectorSell99,032$49.51$4,903,074.32View SEC Filing  
1/9/2014Stuart EssigDirectorSell114,431$49.58$5,673,488.98View SEC Filing  
8/30/2013Richard GorelickVPSell3,000$40.79$122,370.00View SEC Filing  
8/23/2013Deborah LeonettiVPSell8,906$41.68$371,202.08View SEC Filing  
8/19/2013Brian LarkinVPSell7,490$41.90$313,831.00View SEC Filing  
8/19/2013John Henneman IIICFOSell30,000$42.08$1,262,400.00View SEC Filing  
8/1/2013Judith OgradyVPSell1,000$39.50$39,500.00View SEC Filing  
7/30/2013Judith OgradyVPSell2,000$38.50$77,000.00View SEC Filing  
5/31/2013Jerry E CorbinVPSell1,876$38.07$71,419.32View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Latest Headlines for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Source:
DateHeadline
americanbankingnews.com logo Analysts Expect Integra LifeSciences Holdings Corporation (NASDAQ:IART) Will Announce Quarterly Sales of $282.89 Million
www.americanbankingnews.com - July 21 at 5:22 PM
americanbankingnews.com logoContrasting Lombard Medical (EVAR) & Integra LifeSciences Holdings Corporation (IART)
www.americanbankingnews.com - July 19 at 4:12 PM
americanbankingnews.com logoZacks: Analysts Expect Integra LifeSciences Holdings Corporation (NASDAQ:IART) Will Announce Earnings of $0.44 Per Share
www.americanbankingnews.com - July 19 at 2:44 PM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation (NASDAQ:IART) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - July 17 at 2:50 PM
nasdaq.com logoIntegra LifeSciences to Host Its Second Quarter 2017 Earnings Results ...
www.nasdaq.com - July 12 at 4:26 AM
finance.yahoo.com logoIntegra LifeSciences to Host Its Second Quarter 2017 Earnings Results Conference Call on July 26, 2017
finance.yahoo.com - July 11 at 11:25 PM
americanbankingnews.com logoCantor Fitzgerald Reiterates "Overweight" Rating for Integra LifeSciences Holdings Corporation (IART)
www.americanbankingnews.com - July 10 at 3:46 PM
americanbankingnews.com logoCantor Fitzgerald Comments on Integra LifeSciences Holdings Corporation's FY2017 Earnings (IART)
www.americanbankingnews.com - July 6 at 9:17 AM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation (IART) Earns Overweight Rating from Analysts at Cantor Fitzgerald
www.americanbankingnews.com - June 29 at 6:42 PM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation (IART) Downgraded by Zacks Investment Research to "Sell"
www.americanbankingnews.com - June 29 at 12:52 AM
americanbankingnews.com logoOppenheimer Holdings, Inc. Analysts Give Integra LifeSciences Holdings Corporation (IART) a $60.00 Price Target
www.americanbankingnews.com - June 25 at 11:06 PM
americanbankingnews.com logo$282.89 Million in Sales Expected for Integra LifeSciences Holdings Corporation (IART) This Quarter
www.americanbankingnews.com - June 25 at 9:46 AM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation (IART) Expected to Post Earnings of $0.44 Per Share
www.americanbankingnews.com - June 23 at 11:27 AM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation (IART) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 20 at 3:04 PM
feeds.benzinga.com logoIntegra LifeSciences to Hold Second International Tissue Technologies Symposium on June 15 - 16, 2017 in Berlin, Germany
feeds.benzinga.com - June 15 at 4:25 AM
americanbankingnews.com logoEndologix (ELGX) & Integra Lifesciences Holdings Corp (IART) Financial Analysis
www.americanbankingnews.com - June 10 at 7:54 AM
finance.yahoo.com logoIntegra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold
finance.yahoo.com - June 1 at 6:38 PM
americanbankingnews.com logoFY2018 EPS Estimates for Integra Lifesciences Holdings Corp (IART) Lowered by Jefferies Group
www.americanbankingnews.com - June 1 at 12:50 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Expected to Announce Quarterly Sales of $282.89 Million
www.americanbankingnews.com - June 1 at 12:48 PM
americanbankingnews.com logoJefferies Group LLC Reaffirms Buy Rating for Integra Lifesciences Holdings Corp (IART)
www.americanbankingnews.com - May 31 at 1:16 PM
seekingalpha.com logoIntegra LifeSciences: Two Recent Acquisitions Set To Drive Substantial Upside
seekingalpha.com - May 30 at 10:42 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Expected to Announce Earnings of $0.44 Per Share
www.americanbankingnews.com - May 30 at 7:38 AM
finance.yahoo.com logoIntegra LifeSciences (IART) Up 8.5% Since Earnings Report: Can It Continue?
finance.yahoo.com - May 29 at 9:43 AM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Director Stuart Essig Sells 135,000 Shares
www.americanbankingnews.com - May 26 at 7:26 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 26 at 2:53 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Director Sells $6,721,400.00 in Stock
www.americanbankingnews.com - May 24 at 7:21 PM
nasdaq.com logoIntegra LifeSciences to Offer aap's LOQTEQ System in the US
www.nasdaq.com - May 24 at 5:40 PM
finance.yahoo.com logoIntegra LifeSciences to Present at Healthcare Conferences in June 2017
finance.yahoo.com - May 24 at 5:40 PM
americanbankingnews.com logoValuEngine Lowers Integra Lifesciences Holdings Corp (IART) to Hold
www.americanbankingnews.com - May 23 at 5:04 PM
reuters.com logoBRIEF-Integra Lifesciences Holdings Corp signs an agreement with AAP Implantate AG
www.reuters.com - May 23 at 11:24 AM
finance.yahoo.com logoIntegra LifeSciences Announces Agreement with aap to Distribute LOQTEQ® Distal Radius System
finance.yahoo.com - May 23 at 11:24 AM
finance.yahoo.com logoIntegra LifeSciences Announces the European Launch of Integra® Dermal Regeneration Template Single Layer "Thin"
finance.yahoo.com - May 17 at 10:04 AM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Given a $54.00 Price Target by Oppenheimer Holdings Inc. Analysts
www.americanbankingnews.com - May 15 at 2:34 PM
finance.yahoo.com logoIntegra LifeSciences launches SurgiMend® MP Collagen Matrix for Hernia Repair
finance.yahoo.com - May 12 at 6:30 PM
finance.yahoo.com logoETFs with exposure to Integra LifeSciences Holdings Corp. : May 11, 2017
finance.yahoo.com - May 11 at 6:23 PM
americanbankingnews.com logo Analysts Anticipate Integra Lifesciences Holdings Corp (IART) Will Post Quarterly Sales of $282.89 Million
www.americanbankingnews.com - May 6 at 8:47 AM
americanbankingnews.com logoInsider Selling: Integra Lifesciences Holdings Corp (IART) Director Sells 15,658 Shares of Stock
www.americanbankingnews.com - May 5 at 8:11 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) VP Sells $636,542.15 in Stock
www.americanbankingnews.com - May 5 at 8:11 PM
americanbankingnews.com logo Analysts Anticipate Integra Lifesciences Holdings Corp (IART) to Post $0.44 Earnings Per Share
www.americanbankingnews.com - May 4 at 1:24 PM
finance.yahoo.com logoIntegra LifeSciences to Present at Healthcare Conferences in May 2017
finance.yahoo.com - May 3 at 5:26 PM
americanbankingnews.com logoPositive Media Coverage Very Likely to Impact Integra Lifesciences Holdings Corp (IART) Stock Price
www.americanbankingnews.com - May 2 at 6:10 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Given New $48.00 Price Target at Royal Bank of Canada
www.americanbankingnews.com - May 2 at 7:54 AM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 1 at 6:38 PM
americanbankingnews.com logoJefferies Group Comments on Integra Lifesciences Holdings Corp's Q4 2017 Earnings (IART)
www.americanbankingnews.com - May 1 at 11:34 AM
americanbankingnews.com logoQ2 2017 EPS Estimates for Integra Lifesciences Holdings Corp Raised by Northcoast Research (IART)
www.americanbankingnews.com - May 1 at 8:11 AM
americanbankingnews.com logoFavorable Press Coverage Likely to Impact Integra Lifesciences Holdings Corp (IART) Stock Price
www.americanbankingnews.com - April 29 at 8:50 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Given Buy Rating at Jefferies Group LLC
www.americanbankingnews.com - April 29 at 1:05 AM
finance.yahoo.com logoIntegra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q1, 2017 By the Numbers : April 28, 2017
finance.yahoo.com - April 28 at 6:46 PM
americanbankingnews.com logoJefferies Group Analysts Raise Earnings Estimates for Integra Lifesciences Holdings Corp (IART)
www.americanbankingnews.com - April 28 at 1:25 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Forecasted to Post Q2 2017 Earnings of $0.44 Per Share
www.americanbankingnews.com - April 28 at 7:54 AM

Social

Chart

Integra LifeSciences Holdings Corporation (IART) Chart for Sunday, July, 23, 2017

This page was last updated on 7/23/2017 by MarketBeat.com Staff